Engineered virus-like particles (eVLPs) are revolutionizing the field of gene delivery and editing. These particles are designed to safely and effectively deliver macromolecules, such as mRNAs, proteins, or ribonucleoproteins (RNPs), into cells. While Adeno-associated virus (AAV) vectors have been
Some studies presents an in-depth analysis of how the density of microorganisms, or microbial load, in the human gut can impact overall health and contribute to various diseases. This relatively new dimension of gut microbiome research, as illustrated by the study conducted by the Bork group at
The integration of artificial intelligence (AI) in healthcare has been a topic of significant interest and research. One of the latest advancements in this field is Chat GPT Plus, an AI tool designed to assist physicians in making medical diagnoses. This article delves into a comprehensive study
The increasing prevalence of foot-related pathologies, especially among the aging population, highlights the urgent need for advanced diagnostic tools in radiology and orthopedics. Addressing this necessity, Vienna-based ImageBiopsy Lab (IB Lab) has introduced IB Lab FROG, an innovative AI-powered
The rise of artificial intelligence (A.I.) in the pharmaceutical industry signifies a transformative period, placing unprecedented power in the hands of tech-driven drug discovery and igniting debates about innovation, control, and patient safety. Subject to regulatory scrutiny, the FDA has
In the world of modern medicine, finding innovative, safer, and more effective treatments for cancer remains a relentless pursuit. Researchers from the University of Nottingham have turned their attention to an unassuming yet potent ally in this fight—the parasitic fungus Cordyceps militaris. S
Cancer research has entered a new era with the advent of patient-derived organoids (PDOs). These sophisticated three-dimensional (3D) models, grown from patient cells, have revolutionized our understanding of tumors and their microenvironments. By mimicking the complexity of human tumors, PDOs have
A groundbreaking study published in The Lancet has revealed promising results for the use of stem-cell-derived corneal implants in restoring vision for patients suffering from limbal stem cell deficiency (LSCD). This condition, which leads to significant vision impairment due to the loss of corneal
Insilico Medicine, an AI-based drug developer, has made significant strides with its lead candidate, ISM001-055, in the treatment of idiopathic pulmonary fibrosis (IPF). Following promising results from a Phase IIa trial, the company is now gearing up for potentially pivotal clinical trials that
Imagine a common over-the-counter pain reliever having the potential to alleviate the symptoms of a rare genetic disorder that currently lacks any formal treatment. This possibility could mark a significant breakthrough for patients who face enormous challenges and discomfort due to their
